SOURCE: https://www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market FETCHED: 2026-10-18T17:05:46.381789 Isothermal Nucleic Acid Amplification Technology Market Report, 2023-2030 Grand View Research Logo Home Industries Automotive & Transportation Biotechnology Bulk Chemicals Clinical Diagnostics Consumer Goods Energy & Power Healthcare IT Explore All Industries Companies Abbott BASF DuPont GE HealthCare Johnson & Johnson Medtronic Microsoft Explore All Companies Services Astra (ESG Solution) Brainshare (Consulting) Consumer Insights Custom Research Services Horizon Databooks Investment Insights Market Research Reports Market Trend Reports Pipeline (Supplier DB) Prism AI Signal (Pricing Database) Contact Us Prism AI 30,000 reports 1.2 million data points One conversation Explore with AI Collapse Toggle navigation Reports Consumer Goods » Beauty & Personal Care Clothing, Footwear & Accessories Consumer F&B Electronic & Electrical Homecare & Decor Semiconductors & Electronics » Display Technologies Electronic Security Systems Electronic Devices Semiconductors Sensors & Controls Specialty & Fine Chemicals » Catalysts and Enzymes Food Additives and Nutricosmetics Renewable Chemicals Specialty and Bio-based Polymers Food & Beverages » Animal Feed & Feed Additives Food Safety & Processing Nutraceuticals & Functional Foods Processed & Frozen Foods Advanced Materials » Advanced Interior Materials Green Building Materials Micro Molding and Microspheres Nanoparticles Smart Textiles Glass, Ceramics and Fibers Healthcare » Biotechnology Clinical Diagnostics Healthcare IT Medical Devices Medical Imaging Pharmaceuticals Animal Health Technology » Automotive and Transportation Communications Infrastructure Communication Services Digital Media HVAC & Construction Network Security Next Generation Technologies Bulk Chemicals » Agrochemicals & Fertilizers Disinfectants & Preservatives Drilling & Extraction Equipments Organic Chemicals Paints, Coatings & Printing Inks Personal Care & Cosmetics Petrochemicals Plastics, Polymers & Resins Water & Sludge Treatment Services Brainshare Consulting Custom Research Services Consumer Insights Horizon Databooks Investment Insights Market Research Reports Market Trend Reports Pipeline - Procurement Intelligence Signal - Commodity Pricing Astra ESG solutions Prism AI About Us Who We Are Why Choose Us Research Methodology Client Testimonials Conferences Media Citations Contact Career Insights Research Insights Ongoing Reports Case Studies Press Room Blogs Log in Sign up Report Summary Table of Contents Segmentation Methodology Download Free Sample Buy This Report Customize This Report --> Report Page --> Home » Biotechnology » Isothermal Nucleic Acid Amplification Technology Market Report, 2023-2030 GVR Report cover Isothermal Nucleic Acid Amplification Technology Market (2023 - 2030) Size, Share & Trends Analysis Report By Product, By Technology (NASBA, HDA, LAMP, SDA, SPIA, NEAR), By Application, By End-use, By Region, And Segment Forecasts Report Summary Table of Contents Segmentation Methodology Download Free Sample Buy This Report Customize This Report --> Market Size, 2022 $4.2B Market Estimate, 2026 $6.7B Market Forecast, 2030 $10.7B CAGR, 2023–2030 12.3% Report Overview The global isothermal nucleic acid amplification technology market size was valued at USD 4.2 billion in 2022 and is projected to grow from USD 6.7 billion in 2026 to USD 10.7 billion by 2030, at a CAGR of 12.3% from 2023 to 2030. North America dominated the market, accounting for a revenue share of 42.7% in 2022. The Isothermal Nucleic Acid Amplification Technology (INAAT) is experiencing a notable surge in demand as a molecular testing technique, primarily attributed to the growing prevalence of infectious diseases. Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases To learn more about this report, Download Free Sample Report Tuberculosis, hepatitis, and influenza are among the leading causes of deaths caused by infectious diseases, especially in the developing countries. As a result, demand for rapid, user-friendly, and disease-specific testing options is expected to boost the adoption of INAAT offerings. To learn more about this report, Download Free Sample Report Furthermore, the COVID-19 pandemic has positively affected the market growth by expanding the demand for rapid and accurate testing alternatives for the detection of the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and have secured emergency use approvals for such products from the U.S. FDA. For instance, commercially available products in this domain include Grifols Diagnostic Solutions Inc.’s Procleix SARS-CoV-2 assay and Lucira Health, Inc.’s Lucira CHECK-IT COVID-19 test kit. Such strategic initiatives fueled by the COVID-19 pandemic are likely to provide a significant stimulus to the market growth in the near future. Rapid advancements in existing amplification technologies along with the introduction of novel technologies such as Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA) are opening new avenues for applications of INAAT products. For instance, a research paper published in the Analyst Journal in June 2022 demonstrated the development of a smartphone integrated instrument that can rapidly test for Zika virus in a single blood drop using the LAMP technology. Such developments are likely to boost the market penetration of the technique in the near future. Amplification techniques such as PCR are limited by requirement of instrumentation capable of thermal cycling and temperature control, which limits the applications of the technique for point-of-care applications. This creates significant growth opportunities for isothermal amplification techniques for use in molecular diagnostics , as these techniques have a lower energy demand and enable assay incubation in portable battery-powered devices. Similarly, strategic partnerships between companies that manufacture INAAT diagnostics and associated products are likely to boost market expansion prospects. For instance, Merck KGaA offers custom LAMP primers in partnership with New England Biolabs for applications of LAMP technologies in life sciences research and molecular diagnostics. However, a critical factor limiting the market growth is the regulatory framework governing the development of INAAT-based diagnostics. Regulatory agencies such as the U.S. FDA, EMEA, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, have stringent protocols for monitoring the manufacturing processes for INAAT production, which increases the challenges associated with INAAT manufacturing. Furthermore, lower awareness levels and uncertainty in regulations for INAAT-based diagnostics lead to restricted commercialization of INAAT products. In addition, the lack of a robust reimbursement framework in developed markets, such as the U.S., can significantly limit the purchasing power of the buyers. Such factors can impede market growth in the over the forecast period. Product Insights The reagents segment captured market share of 61.62% in 2022 due to their extensive usage in hospitals and primary healthcare settings, as well as increasing availability of polymerases with high strand displacement capabilities. Furthermore, with growth in the market penetration of INAAT diagnostics expected in the near future, adoption of associated reagents is projected to grow at a significant rate over the forecast period. Instrument segment is estimated to register considerable CAGR owing to rising investments for R&D in development of novel diagnostics for emerging infectious diseases such as COVID-19 are driving an increasing demand for INAAT instruments segment. Similarly, introduction of advanced diagnostic devices with enhanced accuracy, portability, and speed can considerably boost the market prospects for INAAT instruments for prevention of disease outbreaks. Technology Insights Loop-mediated isothermal amplification (LAMP) accounted for the largest market share of 16.10% in 2022. The technology enables multiple modes of detection such as use of real-time fluorescence using intercalators, or lateral flow and agarose gel detection. As a result, the technique can detect a broad range of RNA and DNA targets, such as Zika virus and SARS-CoV-2 virus, in human samples. Furthermore, demand for the technique is supported by its tolerance to inhibitors that enables use of crude samples and minimally purified nucleic acids. The transcription mediated amplification (TMA) technology segment is projected to register fastest CAGR during the forecast period. Demand for this technology is fueled by increasing scientific awareness about its potential benefits, such as requirement of fewer steps and lesser processing time, for blood screening and diagnostic applications. Further, technological advancements along with growing investments by market players are expected to offer favorable environment for segment growth by 2030. Application Insights Infectious disease application segment accounted for the dominant share of 35.25% in 2022. Recent introduction of specific INAAT kits, and increasing incidence of HIV, hepatitis A & B, and sexually transmitted diseases are key factors anticipated to fuel the segment growth. Moreover, rising concerns over antimicrobial resistance and increasing focus on prevention of epidemic outbreaks in developing countries is expected to further propel the segment growth. Blood screening segment is projected to register considerable CAGR during the forecast period. Certain factors such as rising number of blood transfusions and associated blood testing requirements across the globe are likely to have positive impact on the segment growth by 2030. Here, INAAT is widely used for evaluation of blood quality by screening of transfused blood for presence of any infectious organisms. Furthermore, increasing research activities for development of INAAT devices capable of detecting molecular biomarkers and multiple blood-borne pathogens are anticipated to broaden the growth prospects for the market. End-use Insights Hospitals segment held the largest market share of 40.13% in 2022. This can be attributed to the development of miniaturized point-of-care INAAT instruments that enable single-level access for hospital-based analysis. Similarly, increasing throughput and automation offered by such technologies for processing of a large number of samples are expected to boost the segment growth. To learn more about this report, Download Free Sample Report Central and reference laboratories end-use segment is expected to exhibit significant growth over the forecast period due to an increasing number of reference laboratories and rising adoption of molecular diagnostic techniques in such laboratories. In addition, increasing funding from various public agencies such as the U.S. CDC and NIH is boosting the adoption of rapid analysis technologies for the mitigation of infectious diseases. Regional Insights North America held the largest market share in 2022 with revenue share of 42.68% due to the established research infrastructure and growth in demand for nucleic acid amplification-based diagnostics for prevention of infectious diseases in the region. Furthermore, a high per capita expenditure on healthcare and increasing focus on point-of-care diagnostic methods is anticipated to drive the market growth. To learn more about this report, Download Free Sample Report Asia Pacific is expected to register the fastest CAGR during the forecast period. The increasing prevalence of chronic conditions, growing involvement of market players in the region and rising investments for research & development are estimated to play a major role in growth of Asia Pacific market during the forecast period. Key Companies & Market Share Insights The INAAT market is highly competitive due to the adoption of major strategic initiatives by key players. For instance, in May 2022, Meridian Bioscience, Inc. launched the new Lyo-Ready Direct RNA/DNA LAMP and Lyo-Ready Direct DNA LAMP Saliva Mix master mixes for isothermal amplification applications. Moreover, in February 2023, Sherlock Biosciencesannounced acquisition of Sense Biodetection in order to consolidate its position in the INAAT market. Some of the key players in the global isothermal nucleic acid amplification technology market include: Alere, Inc. bioMerieux SA Eiken Chemical Co. Ltd Hologic Inc.(Gen-Probe) Lucigen Meridian Bioscience, Inc. Ustar Biotechnologies Ltd. QIAGEN Quidel Corporation Thermo Fisher Scientific, Inc. BD (Becton, Dickinson & Company) OptiGene Limited Isothermal Nucleic Acid Amplification Technology Market Report Scope Report Attribute Details Market size in 2022 USD 4.2 billion Estimated market size in 2026 USD 6.7 billion Projected market size by 2030 USD 10.7 billion Growth rate CAGR of 12.3% from 2023 to 2030 Base year for estimation 2022 Historical data 2018 - 2021 Forecast period 2023 - 2030 Report updated June 2023 Quantitative units Revenue in USD million and CAGR from 2023 to 2030 Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Segments covered Product, technology, application, end-use, region Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope U.S.; Canada; U.K.; Germany; France; Italy; Spain; Sweden; Denmark; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait Key companies profiled Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd; Hologic Inc.(Gen-Probe); Lucigen; Meridian Bioscience, Inc.; Ustar Biotechnologies Ltd.; QIAGEN; Quidel Corporation; Thermo Fisher Scientific, Inc; BD (Becton, Dickinson & Company); OptiGene Limited Customization scope Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options Global Isothermal Nucleic Acid Amplification Technology Market Report Segmentation This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global isothermal nucleic acid amplification technology market report on the basis of product, technology, application, end-use, and region: Product Outlook (Revenue, USD Million, 2018 - 2030) Instruments Reagent Technology Outlook, (Revenue, USD Million, 2018 - 2030) NASBA HDA LAMP SDA SPIA NEAR TMA RCA RPA SMAP2 Others Application Outlook (Revenue, USD Million, 2018 - 2030) Blood Screening Infectious Disease Diagnostics Cancer Others End-use Outlook (Revenue, USD Million, 2018 - 2030) Hospitals Central & Reference Labs Others Regional Outlook (Revenue, USD Million, 2018 - 2030) North America U.S. Canada Europe U.K. Germany France Italy Spain Sweden Denmark Norway Asia Pacific Japan China India Australia South Korea Thailand Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa Saudi Arabia UAE Kuwait Frequently Asked Questions About This Report Which region dominated the isothermal nucleic acid amplification technology market? North America dominated the isothermal nucleic acid amplification technology market with a share of 42.7% in 2022. This is attributable to rising healthcare awareness coupled with growth in demand for nucleic acid amplification-based diagnostics to prevent infectious diseases in the region. How big is the isothermal nucleic acid amplification technology market? The global isothermal nucleic acid amplification technology market size was valued at USD 4.2 billion in 2022 and is estimated at USD 6.7 billion for 2026. What is the isothermal nucleic acid amplification technology market growth? The global isothermal nucleic acid amplification technology market is expected to grow at a CAGR of 12.3% from 2023 to 2030, reaching USD 10.7 billion by 2030. Who are the key players in isothermal nucleic acid amplification technology market? Some key players operating in the isothermal nucleic acid amplification technology market include Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd; Hologic Inc.(Gen-Probe); Lucigen; Meridian Bioscience, Inc.; Ustar Biotechnologies Ltd.; QIAGEN; Quidel Corporation; Thermo Fisher Scientific, Inc; BD (Becton, Dickinson & Company); OptiGene Limited What are the factors driving the isothermal nucleic acid amplification technology market? Key factors driving the isothermal nucleic acid amplification technology market growth include the increase in demand for molecular testing techniques to mitigate the rising prevalence of infectious diseases, as well as the increasing utility of rapid, user-friendly, and disease-specific testing options offered by INAAT techniques. About the Author(s) Biotechnology Research Team Healthcare · Biotechnology This report was authored by the biotechnology research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the biotechnology segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication. Last Updated: July 2026 Speak to Analyst Request a Free Sample Report Details ID: GVR-1-68038-588-5 Report Pages: 150 Format: PDF, Excel, Dashboard Published: June 2023 Buy This Report --> Jump to Content Need a Tailored Report? Customize this report to your needs - add regions, segments, or data points, with 20% free customization. Customize This Report Or view our licence options: Buy This Report --> GET A FREE SAMPLE --> Get Free Sample Report This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself. Download FREE Sample Or view our licence options: Buy This Report ISO 9001:2015 & 27001:2022 Certified We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy . Share E-mail Save Print × Loading... Trusted market insights - try a free sample See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs. Customize This Report Download Free Sample GDPR & CCPA Compliant ISO 9001 Certified ISO 27001 Certified ESOMAR Member Included in Horizon account 30K+ Global Market Reports 120K+ Country Reports 1.2M+ Market Statistics 200K+ Company Profiles Industry insights and more --> Grand View Research is trusted by industry leaders worldwide --> Grand View Research Global market intelligence, research and data solutions that help businesses make informed strategic decisions. Global Headquarters One Embarcadero Center, Suite 1200, San Francisco, CA 94111 United States Products & Services Horizon — Market Database Signal — Pricing Intelligence Pipeline — Procurement Intelligence Brainshare — Consulting Custom Research Prism AI NEW Company Who We Are Why Choose Us Client Testimonials Media Citations Press Room Contact Us Connect with GVR For report inquiries, custom research, subscriptions and other market intelligence requirements. Phone +1-415-349-0058 +1-888-202-9519 Email [email protected] ISO 9001 Certified ISO 27001 Certified ESOMAR Member GDPR & CCPA Compliant Follow GVR © 2026 Grand View Research, Inc. All rights reserved. Customer FAQ How to Order Privacy Policy Terms of Use Sitemap Please wait while we are processing your request... -->